Showing results (31-40 of 191) with videos related to
Sort By:
Pageof 20
Current Hematologic Malignancy Reports|June 8, 2022
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic MalignanciesRyan J Stubbins, Sophia Korotev, Lucy A GodleyOncotargets and Therapy|July 10, 2010
An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromesJacqueline S Garcia, Nitin Jain, Lucy A GodleyExpert Review of Molecular Diagnostics|July 26, 2024
The impact of next-generation sequencing for diagnosis and disease understanding of myeloid malignanciesErica Vormittag-Nocito, Madina Sukhanova, Lucy A GodleyAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 20, 2024
Germline Predisposition in Hematologic Malignancies: Testing, Management, and ImplicationsLucy A Godley, Courtney D DiNardo, Kelly BoltonBlood|December 1, 2022
DDX41-associated susceptibility to myeloid neoplasmsHideki Makishima, Teresa V Bowman, Lucy A GodleyJCO Precision Oncology|January 7, 2022
Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision OncologyGregory W Roloff, Michael W Drazer, Lucy A GodleyGenetics in Medicine : Official Journal of the American College of Medical Genetics|August 19, 2020
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignanciesGregory W Roloff, Lucy A Godley, Michael W DrazerBJC Reports|October 6, 2025
Germline JAK2 R564Q variants presenting as hereditary thrombocytosis: case reportStephanie Franco, Kinga Krawiec, Piotr Strzalka, et al.Annals of the New York Academy of Sciences|January 29, 2014
Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigationsAllison H West, Lucy A Godley, Jane E ChurpekNature Reviews. Cancer|August 25, 2017
Therapy-related myeloid neoplasms: when genetics and environment collideMegan E McNerney, Lucy A Godley, Michelle M Le BeauPageof 20